Funds will be used to advance company’s integrated physiological and digital biomarker platform
News
Tecentriq approved for first-line metastatic NSCLC
Checkpoint inhibitor specifically approved for patients with high PD-L1 expression
NICE expands access for SMA drug Spinraza
Managed access agreement treatment eligibility criteria extended following review
UK bolsters COVID-19 variant testing capabilities with £29.3m investment
New facility will fast-track vaccines for COVID-19 variants to “future-proof the country”
CROY 2021 deadline extended to 18th June
The 2021 Clinical Researcher of the Year – The Americas competitions entry deadline has been extended to the 18th of June.
NHS rolls out 3D heart scans to fast-track diagnosis of heart disease
Scan enables doctors to diagnose coronary heart disease in 20 minutes, according to NHS England
Researchers identify new genetic target for acute myeloid leukaemia
Targeting a specific mutation in the CUX1 gene may offer a ‘new therapy avenue’ for AML patients
Janssen seeks EU approval for first CAR-T therapy cilta-cel
Cilta-cel is an investigational CAR-T cell therapy for the treatment of relapsed/refractory multiple myeloma
AZ’s Farxiga scores US approval in chronic kidney disease
SGLT2 inhibitor approved for high-risk patients with and without type 2 diabetes
IQVIA report forecasts global medicine spending to hit $1.6 trillion in 2025
Report notes a ‘modest’ impact on pre-pandemic drivers of medicine use and spending from COVID-19
UK buys another 60 million doses of Pfizer/BioNTech vaccine
Extra doses will be used for UK’s planned booster vaccination programme in autumn
NHS England announces the departure of chief executive Simon Stevens
Stevens will step down from the leadership role officially on 31 July
Government injects £37m into genomics and data-driven initiatives
Health Secretary reveals government’s plans for UK life sciences ‘transformation’
Calling all pharma marketers
The 2021 Marketer of the Year competition is well underway for entries and is looking for the best and brightest to join the ranks.
First UK-based clinical trial focused viral vector manufacturer announces launch
ViroCell Biologics will meet the growing demand for viral vectors in clinical trials
